Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic

PLoS Med. 2007 Dec;4(12):e334. doi: 10.1371/journal.pmed.0040334.

Abstract

The authors describe CMV retinitis in resource-poor settings and suggest possibilities for management.

MeSH terms

  • AIDS-Related Opportunistic Infections / complications
  • AIDS-Related Opportunistic Infections / diagnosis
  • AIDS-Related Opportunistic Infections / drug therapy*
  • AIDS-Related Opportunistic Infections / epidemiology
  • AIDS-Related Opportunistic Infections / immunology
  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / epidemiology
  • Acquired Immunodeficiency Syndrome / immunology
  • Africa South of the Sahara / epidemiology
  • Anti-Retroviral Agents / economics
  • Anti-Retroviral Agents / therapeutic use*
  • Antiviral Agents / economics
  • Antiviral Agents / therapeutic use*
  • Asia, Southeastern / epidemiology
  • Blindness / epidemiology
  • Blindness / immunology
  • Blindness / prevention & control*
  • Blindness / virology
  • CD4 Lymphocyte Count
  • Cytomegalovirus Retinitis / complications
  • Cytomegalovirus Retinitis / diagnosis
  • Cytomegalovirus Retinitis / drug therapy*
  • Cytomegalovirus Retinitis / epidemiology
  • Cytomegalovirus Retinitis / immunology
  • Developing Countries
  • Disease Outbreaks*
  • Drug Costs
  • Ganciclovir / analogs & derivatives*
  • Ganciclovir / economics
  • Ganciclovir / therapeutic use
  • Health Services Accessibility
  • Humans
  • Mass Screening
  • Ophthalmoscopy
  • Program Development
  • Treatment Outcome
  • Valganciclovir

Substances

  • Anti-Retroviral Agents
  • Antiviral Agents
  • Valganciclovir
  • Ganciclovir